Clinical Trial Update: Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating combined immunotherapy and chemotherapy for infants with acute lymphoblastic leukemia; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Acute Lymphoblastic Leukemia, Pediatric, ALL, Infants | Phase 3 | Status: RECRUITING